text_1: CD44v6 is not associated with constitutive and reprogrammed cancer stem cells driving cancer metastasis.
text_2: Thus, the metastatic process in colorectal cancer is initiated by CSCs through the expression of CD44v6, which is both a functional biomarker and therapeutic target.